Clinical trial · Observational
Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras
Multicentered Observational Prospective Cohort Study on the Treatment of Metastatic Colorectal Cancer and the Role of Evaluating K-Ras
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to describe the treatments received and outcomes of patients with metastatic colorectal cancer, what percentage of these patients have K-Ras mutation of the tumor, and to describe the costs of treatments. Information will also be collected regarding risk factors, variables among treatment centers and patients, and explorative analyses will be done to try to identify factors that impact prognosis and factors that predict tolerability and response to treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Metastatic Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- metastatic colorectal cancer
Primary outcomes (3)
- measure
- percentage of patients enrolled in a clinical trial
- timeFrame
- two years
- measure
- percentage of patients who undergo K-Ras mutation study
- timeFrame
- 2 years
- measure
- Percentage of patients with K-Ras mutation
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologic diagnosis colorectal carcinoma * Metastatic disease * Signed informed consent Exclusion Criteria: * Prior treatment of metastatic colorectal cancer * Refusal or incapability of providing informed consent
References
Publications (0)
Data not yet available